ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,761Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 393

$302K Total Retail Price of All Prescriptions

Rank: 160 out of 393

498 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,446 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 564 444 1 2
LEVOTHYROXINE SODIUM 449 389 2 3
SIMVASTATIN 376 312 3 1
AMLODIPINE BESYLATE 376 330 3 4
ATENOLOL 246 237 5 13
HYDROCHLOROTHIAZIDE 243 209 6 10
METOPROLOL TARTRATE 214 173 7 9
METFORMIN HCL 211 140 8 7
WARFARIN SODIUM 169 155 9 17
PRAVASTATIN SODIUM 162 121 10 18
HYDROCODONE-ACETAMINOPHEN 151 129 S3 11 5
OMEPRAZOLE 130 116 12 6
POTASSIUM CHLORIDE 125 109 13 20
ATORVASTATIN CALCIUM 115 91 14 19
LOSARTAN POTASSIUM 106 91 15 12
LOVASTATIN 104 97 16 14
GLIPIZIDE 100 67 17 32
SERTRALINE HCL 94 75 18 28
ADVAIR DISKUS 92 80 19 53
CITALOPRAM HBR 91 84 20 23
TRIAMTERENE-HCTZ 88 84 21 49
GABAPENTIN 86 64 22 15
FLUTICASONE PROPIONATE 86 59 22 27
ALENDRONATE SODIUM 86 86 22 16
AMITRIPTYLINE HCL 85 46 R 25 72
ALLOPURINOL 85 75 25 26
FUROSEMIDE 79 57 27 8
GEMFIBROZIL 71 57 28 62
FAMOTIDINE 69 48 29 70
ZOLPIDEM TARTRATE 65 54 30 11
DONEPEZIL HCL 62 62 31 34
BENAZEPRIL HCL 62 62 31 40
CLOPIDOGREL 61 47 33 33
DOXAZOSIN MESYLATE 56 56 34 83
PAROXETINE HCL 56 56 34 61
GLYBURIDE 56 38 R 34 46
CLONIDINE HCL 56 46 34 50
TAMSULOSIN HCL 54 54 38 25
SPIRIVA 53 48 39 41
DIOVAN 52 45 40 69
PLAVIX 51 38 41 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.